TherapeuticsMD, Inc.

TherapeuticsMD, Inc.verified

TXMD

Price:

$1.45

Market Cap:

$16.78M

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes b...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2007-05-09

Stock Exchange

NASDAQ

Ticker

TXMD

The PE Ratio as of May 2025 (TTM) for TherapeuticsMD, Inc. (TXMD) is -7.63

According to TherapeuticsMD, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -7.63. This represents a change of 360.09% compared to the average of -1.66 of the last 4 quarters.

TherapeuticsMD, Inc. (TXMD) Historical PE Ratio (quarterly & annually)

How has TXMD PE Ratio performed in the past?

The mean historical PE Ratio of TherapeuticsMD, Inc. over the last ten years is -6.80. The current -7.63 PE Ratio has changed 11.12% with respect to the historical average. Over the past ten years (40 quarters), TXMD's PE Ratio was at its highest in in the December 2024 quarter at 9.84. The PE Ratio was at its lowest in in the December 2015 quarter at -26.38.

Quarterly (TTM)
Annual

Average

-6.80

Median

-3.79

Minimum

-21.11

Maximum

0.45

TherapeuticsMD, Inc. (TXMD) PE Ratio by Quarter and Year

Discovering the peaks and valleys of TherapeuticsMD, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 98.94%

Maximum Annual PE Ratio = 0.45

Minimum Annual Increase = -607.25%

Minimum Annual PE Ratio = -21.11

Quarterly (TTM)
Annual
YearPE RatioChange
2024-4.5598.94%
2023-2.29-607.25%
20220.45-164.66%
2021-0.70-55.56%
2020-1.57-48.44%
2019-3.04-52.96%
2018-6.46-59.94%
2017-16.1428.19%
2016-12.59-40.36%
2015-21.1171.76%

TherapeuticsMD, Inc. (TXMD) Average PE Ratio

How has TXMD PE Ratio performed in the past?

The current PE Ratio of TherapeuticsMD, Inc. (TXMD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-2.13

5-year avg

-1.73

10-year avg

-6.80

TherapeuticsMD, Inc. (TXMD) PE Ratio vs. Peers

How is TXMD’s PE Ratio compared to its peers?

TherapeuticsMD, Inc.’s PE Ratio is less than Aquestive Therapeutics, Inc. (-4.03), less than Evoke Pharma, Inc. (-1.86), less than Adamis Pharmaceuticals Corporation (-0.67), less than Guardion Health Sciences, Inc. (0.69), less than AcelRx Pharmaceuticals, Inc. (-1.14), less than Ironwood Pharmaceuticals, Inc. (-3.18), less than Alkermes plc (13.92), less than Eagle Pharmaceuticals, Inc. (0.65), greater than ANI Pharmaceuticals, Inc. (-53.35), less than Agile Therapeutics, Inc. (-0.65), greater than Alpha Teknova, Inc. (-14.29), less than Cyclo Therapeutics, Inc. (-0.83), less than Petros Pharmaceuticals, Inc. (-0.01), less than Lifecore Biomedical, Inc. (-5.53), greater than Organogenesis Holdings Inc. (-20.13), greater than Cumberland Pharmaceuticals Inc. (-23.21), less than PainReform Ltd. (-0.38),

Build a custom stock screener for TherapeuticsMD, Inc. (TXMD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TherapeuticsMD, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

TherapeuticsMD, Inc. (TXMD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like TherapeuticsMD, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is TherapeuticsMD, Inc.'s PE Ratio?

How is the PE Ratio calculated for TherapeuticsMD, Inc. (TXMD)?

What is the highest PE Ratio for TherapeuticsMD, Inc. (TXMD)?

What is the 3-year average PE Ratio for TherapeuticsMD, Inc. (TXMD)?

What is the 5-year average PE Ratio for TherapeuticsMD, Inc. (TXMD)?

How does the current PE Ratio for TherapeuticsMD, Inc. (TXMD) compare to its historical average?